Close
Smartlab Europe
Inizio Ignite

News

WHO & Republic of Korea Tie-Up For Biomanufacturing Training

The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide training hub when it comes to biomanufacturing. The worldwide training centre will go on...

China Fines Pharmaceutical Firms For Monopolistic Behaviour

Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million yuan, which is equivalent to $19.68 million, and has also confiscated 149 million of revenue...

UCB, Veeva Partner to Advance Clinical Trial Efficiency

Veeva, a company involved in cloud software for the life sciences industry, and UCB, a global biopharmaceutical company, announced a collaboration that will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency. UCB will adopt...

How Does the Body Change in Later Life and How Can These Changes Be Managed?

In the senior stages of life, the human body will have undergone significant changes. Many of these will have a cumulative effect on general health levels in the elderly and may result in the person being at a higher...

PharmaLytica 2023 Returns to Hyderabad: Connecting, Innovating and Ideating for the Future of the Pharma Industry

The highly anticipated 9th edition of the PharmaLytica expo, a premier event in the pharmaceutical industry, is set to take place from June 1st till June 3rd 2023 at HITEX, Hyderabad. Organized by Informa Markets in India, PharmaLytica will bring together industry leaders, innovators, and stakeholders...

ClearPoint Neuro, UCB Enter License Agreement for Gene Therapy Drug Delivery

ClearPoint Neuro, Inc., a global therapy-enabling platform company providing navigation and delivery to the brain, announced that it has entered into a multi-year license agreement with UCB, a global biopharmaceutical leader, to partner on drug delivery platforms for UCB’s...

Touchlight Expands DNA Manufacturing Facility in London

Touchlight, a provider enzymatic DNA production, a critical material in many new genetic medicine treatments, completed the redevelopment and expansion of its UK manufacturing facility, housed in a repurposed Victorian waterworks on the banks of the River Thames. According to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »